30 August 2023 in Journal of Infection and Public Health
In 2021, the Spanish Ministry of Health launched the CIBERPOSTCOVID project to establish what post COVID was. The present study reports the level of agreement among stakeholders on post COVID and its clinical and diagnostic characteristics in the Spanish health system. The agreement on post COVID among clinicians, public health managers, researchers and patients' representatives was explored in a real-time, asynchronous online Delphi. In a two-wave consensus, respondents rated from 1 (total disagreement) to 6 (total agreement) 67 statements related to terminology, duration, etiology, symptoms, impact on quality of life, severity, elements to facilitate diagnosis, applicability in the pediatric population, and risk factors. Consensus was reached when 70 % of ratings for a statement were 5 or 6, with an interquartile range equal or less than 1. A total of 333 professionals and patients participated in this eDelphi study. There was agreement that post COVID was "a set of multi-organic symptoms that persist or fluctuate after acute COVID-19 infection and are not attributable to other causes" with a minimum duration of 3 months. The highest levels of agreement were found in the most frequent symptoms and its impacts on everyday activities. Aspects related to the diagnostic process and the measurement of its severity reached a lower level of consensus. There was agreement on the need to rule out previous health problems and assess severity using validated functional scales. However, no agreement was reached on the risk factors or specific features in the pediatric population. This policy-based consensus study has allowed the characterization of post COVID generating collective intelligence and has contributed to an operational definition applicable in clinical practice, health services management and useful for research purposes in Spain and abroad. Agreements are consistent with existing evidence and reference institutions at European and international level.
1 April 2018 in Revista Espanola de Cardiologia
ECEduardo Barge Caballero
15 February 2025 in Revista Clínica de Medicina de Familia
Objetivos: describir los factores socioeconómicos asociados a una mayor prevalencia de diabetes mellitus tipo 2 (DM2) según área básica de salud (ABS) en Catalunya en 2023. Métodos: estudio observacional transversal de todas las personas de entre 18 y 95 años no institucionalizadas del sistema sanitario público de Catalunya en 2023 con datos agregados por ABS. La fuente de datos fue la estación clínica de atención primaria (ECAP). Se hizo un análisis descriptivo de la prevalencia de DM2 y variables socioeconómicas de las 246 ABS urbanas y las 122 rurales. Se analizó la asociación de estos factores con la prevalencia mediante modelos de regresión lineal múltiple según entorno. Resultados: la prevalencia de DM2 fue igual en ABS urbanas y rurales, pero hubo diferencias en la mayoría de variables socioeconómicas. El modelo de regresión lineal múltiple explicó el 84% de la variabilidad de la prevalencia de DM2 entre ABS urbanas, mostrando una asociación con la edad y la morbilidad de las personas, la proporción de trabajadores de baja cualificación, de personas originarias de países con un producto interior bruto (PIB) inferior al español y el índice socioeconómico territorial. En ABS rurales, el modelo explicó el 74% de la variabilidad, incluyendo, además de las anteriores, la proporción de personas exentas de copago de farmacia y la distancia media a los equipos de Atención Primaria. Conclusiones: la prevalencia de DM2 se asocia a diferentes factores socioeconómicos en ABS urbanas y rurales. Por tanto, las estrategias de planificación y salud pública deberían adaptarse a las características específicas de cada entorno. Palabras clave: diabetes mellitus tipo 2, prevalencia, factores socioeconómicos.
21 June 2025 in Atencion Primaria
To describe health status and health care services of the people included in home care program (HC) through secondary use of data from the public system. Observational population-based study. Primary health care in Catalonia (2022). All people over 65 years of age included in HC matched 1:1 with people not attended in HC by age, sex, socioeconomic level and primary care team (45,578 persons per group, 70.5% women and mean age 86.8 years). People receiving HC. Morbidity, healthcare use and events (hospital admissions, mortality). 53.6% of people in HC had a diagnosis of complex chronic patient and 5.7% of advanced chronic disease, compared to 1.1% and 0.05% in the non-HC population. There were more people in HC with heart failure, dementia, stroke, auricular fibrillation and COPD, with higher drug use and pharmaceutical expenditure (€1,446 vs. €732, ratio 1.98, 95%CI 1.95-2.00). Mortality was 20% in HC and 6% in the non-HC population (ratio 3.3, 95%CI 3.17-3.44). A stratified analysis by age showed a higher complexity, morbidity and events in people between 65 and 80 years of age with respect to those over 80 years of age in HC. The results, which show increased morbidity and complexity in HC, especially in people under 80 years of age, may be useful to better identify care needs of these people and program planning.